Since the US Food and Drug Administration (FDA) implemented a ban on ‘compounded’ versions of Wegovy on 22 May, new ...

The global medical writing market is projected to grow from USD 4.66 billion in 2024 to USD 12.12 billion by 2033, with a CAGR of 11.20% from 2025 to 2033. This growth is driven by the expansion of ...

The global Patient Registry Software Market, valued at US$2.06 billion in 2024 stood at US$2.25 billion in 2025 and is ...

Shares of IQVIA Holdings Inc. IQV slid 1.04% to $158.96 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.14% to 6,305.60 and ...

The global Healthcare Consulting Services Market, valued at US$29.11 billion in 2024, stood at US$32.17 billion in 2025 and ...

IQVIA Holdings Inc. closed 35.62% short of its 52-week high of $252.88, which the company reached on August 29th.

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, unveils AI agents at GTC ...

IQVIA stock may look ready for a breakout, but Adhishthana analysis reveals a complex time spiral that could last until 2030.

IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into ...

IQVIA Holdings Inc. (NYSE: IQV) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Kerri Joseph - Senior Vice President, Investor Relations and Treasury Ari Bousbib ...

IQVIA Reports First-Quarter 2025 Results Revenue of $3,829 million GAAP Net Income of $249 million, Adjusted EBITDA of $883 million GAAP Diluted Earnings per Share of $1.40, Adjusted Diluted ...